Naturally occurring disseminated group B Streptococcus infections in postnatal rats

Comparative Medicine

Volumn 63, Issue 1, 2013, Pages 55-61

  Shuster, Katherine A ^a,b   Hish, Gerald A ^b   Selles, Lindsi A ^b   Chowdhury, Mahboob A ^b   Wiggins, Roger C ^b   Dysko, Robert C ^b   Bergin, Ingrid L ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATHINE PENICILLIN; COTRIMOXAZOLE; DIPHTHERIA TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM ISOLATION; DYING; FEMALE; GROUP B STREPTOCOCCAL INFECTION; MALE; NONHUMAN; PERINATAL PERIOD; RAT; SKIN ABSCESS; TRANSGENE; TREATMENT RESPONSE;

ANIMALS; DISEASE OUTBREAKS; EUTHANASIA, ANIMAL; FEMALE; GENOTYPE; LIVER; PENICILLIN G BENZATHINE; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RODENT DISEASES; SKIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 84875035717     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Ancona RJ, Ferrieri P. 1979. Experimental vaginal colonization and mother-infant transmission of group B streptococci in rats. Infect Immun 26:599-603.
2. Arias-Camison JM. 2003. Late-onset group B streptococcal infection from maternal expressed breast milk in a very low-birth-weight infant. J Perinatol 23:691-692.
3. Becker ID, Robinson OM, Bazán TS, López-Osuna M, Kretschmer RR. 1981. Bactericidal capacity of newborn phagocytes against group B β-hemolytic streptococci. Infect Immun 34:535-539.
4. Bromberger P, Lawrence JM, Braun D, Saunders B, Contreras R, Petitti DB. 2000. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics 106:244-250.
5. Cairo MS. 1989. Neonatal neutrophil host defense. Prospects for immunologic enhancement during neonatal sepsis. Am J Dis Child 143:40-46.
6. Cairo MS, Mauss D, Kommareddy S, Norris K, van de Ven C, Modanlou H. 1990. Prophylactic or simultaneous administration of recombinant human granulocyte colony-stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats. Pediatr Res 27:612-616.
7. Cairo MS, Plunkett JM, Mauss D, van de Ven C. 1990. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis. Blood 76:1788-1794.
8. Centers for Disease Control. [Internet]. 2009 GBS surveillance report - active bacterial core surveillance. [Cited 20 October 2010]. Available at: http://www.cdc.gov/abcs/reports-findings/survreports/gbs09.html.
9. Centers for Disease Control. [Internet]. 2010 guidelines for the prevention of perinatal group B streptococcal disease. [Cited 20 October 2010]. Available at: http://www.cdc.gov/groupBstrep/guidelines/provisional-recs.htm.
10. Charles River Laboratories. [Internet]. Health reports indexed by area for Charles River animal colonies in North America. [Cited 8 March 2012]. Available at: http://www.criver.com/en-US/ProdServ/ByType/ResModOver/health/ pages/indexbyarea.aspx.
11. Charles River Laboratories. [Internet]. Laboratory animal infectious agents and diseases. [Cited 8 March 2012]. Available at: http://www.criver.com/ en-US/TrainEducation/RMS/InfectiousAgent/Pages/home.aspx.
12. Christensen RD, MacFarlane JL, Taylor NL, Hill HR, Rothstein G. 1982. Blood and marrow neutrophils during experimental group B streptococcal infection: quantification of the stem cell, proliferative, storage, and circulating pools. Pediatr Res 16:549-553.
13. Christensen RD, Rothstein G. 1980. Exhaustion of mature marrow neutrophils in neonates with sepsis. J Pediatr 96:316-318.
14. Christensen RD, Rothstein G. 1984. Pre- and postnatal development of granulocytic stem cells in the rat. Pediatr Res 18:599-602.
15. Christensen RD, Rothstein G, Anstall HB, Bybee B. 1982. Granulocyte transfusions in neonates with bacterial infection, neutropenia, and depletion of mature marrow neutrophils. Pediatrics 70:1-6.
16. Christensen RD, Shigeoka AO, Hill HR, Rothstein G. 1980. Circulating and storage neutrophil changes in experimental type II group B streptococcal sepsis. Pediatr Res 14:806-808.
17. Dow SW, Jones RL, Thomas TN, Linn KA, Hamilton HB. 1987. Group B streptococcal infection in 2 cats. J Am Vet Med Assoc 190:71-72.
18. Eldar A, Bejerano Y, Livoff A, Horovitcz A, Bercovier H. 1995. Experimental streptococcal meningoencephalitis in cultured fish. Vet Microbiol 43:33-40.
19. Fassi A, Sangalli F, Maffi R, Colombi F, Mohamed EI, Brenner BM, Remuzzi G, Remuzzi A. 1998. Progressive glomerular injury in the MWF rat is predicted by inborn nephron deficit. J Am Soc Nephrol 9:1399-1406.
20. Ferrieri P, Burke B, Nelson J. 1980. Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes. Infect Immun 27:1023-1032.
21. Geistfeld JG, Weisbroth SH, Jansen EA, Kumpfmiller D. 1998. Epizootic of group B Streptococcus agalactiae serotype V in DBA/2 mice. Lab Anim Sci 48:29-33.
22. Godambe S, Shah PS, Shah V. 2005. Breast milk as a source of late-onset neonatal sepsis. Pediatr Infect Dis J 24:381-382.
23. Gregory J, Hey E. 1972. Blood neutrophil response to bacterial infection in the first month of life. Arch Dis Child 47:747-753.
24. Hansen AK. 2000. Handbook of laboratory animal bacteriology. Boca Raton (FL): CRC Press.
25. Hill HR. 1987. Biochemical, structural, and functional abnormalities of polymorphonuclear leukocytes in the neonate. Pediatr Res 22:375-382.
26. Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, Lynfield R, Thomas A, Zansky S, Gershman K, Albanese BA, Schaffner W, Schrag SJ. 2008. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J 27:1057-1064.
27. Kanto WP, Baker CJ. 2003. New recommendations for prevention of early-onset group B streptococcal disease in newborns. Pediatr Rev 24:219-221.
28. Kasper DL, Braunwald E, Hauser S, Longo D, Jameson JL, Fauci AS. 2004. Harrison's principles of internal medicine, 16th ed. New York (NY): McGraw-Hill Professional.
29. Keefe GP. 1997. Streptococcus agalactiae mastitis: a review. Can Vet J 38:429-437.
30. Kornblatt AN, Adams RL, Barthold SW, Cameron GA. 1983. Canine neonatal deaths associated with group B streptococcal septicemia. J Am Vet Med Assoc 183:700-701.
31. Korzhova W, Lisitsina NT, Smirnova EI, Kiseleva LA. 1976. [Influence of antibiotics of the penicillin series on the fetal and newborn development of rats]. Biull Eksp Biol Med 82:864-866. [Article in Russian].
32. Lanari M, Serra L, Cavrini F, Liguori G, Sambri V. 2007. Late-onset group B streptococcal disease by infected mother's milk detected by polymerase chain reaction. New Microbiol 30:253-254.
33. Lin F, Sintchenko V, Kong F, Gilbert GL, Coiera E. 2009. Commonly used molecular epidemiology markers of Streptococcus agalactiae do not appear to predict virulence. Pathology 41:576-581.
34. Macconi D, Bonomelli M, Benigni A, Plati T, Sangalli F, Longaretti L, Conti S, Kawachi H, Hill P, Remuzzi G, Remuzzi A. 2006. Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury. Am J Pathol 168:42-54.
35. MacFarquhar JK, Jones TF, Woron AM, Kainer MA, Whitney CG, Beall B, Schrag SJ, Schaffner W. 2010. Outbreak of late-onset group B Streptococcus in a neonatal intensive care unit. Am J Infect Control 38:283-288.
36. Manroe BL, Rosenfeld CR, Weinberg AG, Browne R. 1977. The differential leukocyte count in the assessment and outcome of early-onset neonatal group B streptococcal disease. J Pediatr 91:632-637.
37. Moore JC, Muckett PJ, Hughes MJ. 2001. Age-dependent presence of antibodies in rat dams, capable of conferring protection against group B Streptococcus infection in neonates. FEMS Microbiol Lett 202:125-127.
38. Novales JS, Salva AM, Modanlou HD, Kaplan DL, del Castillo J, Andersen J, Medlock ES. 1993. Maternal administration of granulocyte colony-stimulating factor improves neonatal rat survival after a lethal group B streptococcal infection. Blood 81:923-927.
39. Onile BA. 1985. Review of group B streptococci and their infections. Afr J Med Med Sci 14:131-143.
40. Raymond J, Armengaud JB, Lambe C, Tchetchoua A, Moulin F, Lebon P, Poyart C, Gendrel D. 2007. Late-onset neonatal infections caused by group B Streptococcus associated with viral infection. Pediatr Infect Dis J 26:963-965.
41. Remuzzi A, Puntorieri S, Alfano M, Macconi D, Abbate M, Bertani T, Remuzzi G. 1992. Pathophysiologic implications of proteinuria in a rat model of progressive glomerular injury. Lab Invest 67:572-579.
42. Schenkman DI, Rahija RJ, Klingenberger KL, Elliott JA, Richter CB. 1994. Outbreak of group B streptococcal meningoencephalitis in athymic mice. Lab Anim Sci 44:639-641.
43. Schuit KE, DeBiasio R. 1980. Kinetics of phagocyte response to group B streptococcal infections in newborn rats. Infect Immun 28:319-324.
44. Tran T-VP, Weisman LE. 2004. Dexamethasone effects on group B streptococcal infection in newborn rats. Pediatr Infect Dis J 23: 47-52.
45. Warejcka DJ, Goodrum KJ, Spitznagel JK. 1985. Toxicity of group B Streptococcus agalactiae in adult rats. Infect Immun 48:560-564.
46. Weeks JW, Myers SR, Lasher L, Goldsmith J, Watkins C, Gall SA. 1997. Persistence of penicillin G benzathine in pregnant group B streptococcus carriers. Obstet Gynecol 90:240-243.
47. Weisman LE, McKinney L, Villalobos R. 1990. Systemic group B streptococcal disease in the neonate: characterization of an oral colonization model using the suckling rat. Microbiol Immunol 34:755-764.
48. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman LB, Wiggins RC. 2005. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16:2941-2952.
49. Widger J, O'Connell NH, Stack T. 2009. Breast milk causing neonatal sepsis and death. Clin Microbiol Infect 16:1796-1798.
50. Wittler RR, Harris RW, Paine DD. 1999. Failure of γ-interferon to decrease mortality from group B streptococcal sepsis in neonatal rats. Biol Neonate 76:125-128.
51. Zeligs BJ, Armstrong CD, Walser JB, Bellanti JA. 1982. Age-dependent susceptibility of neonatal rats to group B streptococcal type III infection: correlation of severity of infection and response of myeloid pools. Infect Immun 37:255-263.